Advice
following an abbreviated submission
ethinylestradiol 20microgram/desogestrel 150microgram and ethinylestradiol 30microgram/desogestrel 150microgram (Gedarel®) is accepted for use within NHS Scotland.
Indication under review: oral contraception.
For patients in whom ethinylestradiol /desogestrel is an appropriate contraceptive, Gedarel® provides an alternative to existing preparations at lower cost.
Download detailed advice69KB (PDF)
Medicine details
- Medicine name:
- ethinylestradiol and desogestrel (Gedarel)
- SMC ID:
- 643/10
- Indication:
- Oral contraceptive
- Pharmaceutical company
- Consilient Health Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 11 October 2010